Skip to main content
Matt Iglesias

Matt Iglesias

Director, Global Patient Safety and ANZ Cluster Lead at AstraZeneca

Jul 27, 2026

0:28
Which uses are mature enough for regulated work? How should organisations manage accuracy, privacy and validation? And what happens to the role of the pharmacovigilance professional as more routine tasks become automated? In this episode, we hear a practical discussion about where AI is being used today, what may be coming next, and how local teams can approach adoption without losing sight of patient safety, compliance and human accountability.
0:52
Just want to comment on the fact that this is not a topic we can avoid and also this is not a topic that will be the same.
1:00
So if we talk about AI in three months, in six months, it will be completely different and there will be new tools, tools will be retired, will be now obsolete and maybe we won't be able to be using the same tools because there will be a breach of privacy and then there will be issues coming through in different ways and there will be opportunities as well.
1:23
It is growing exponentially and we really should make the most of it and share some sort of knowledge and share how we're using it.
1:30
That was

23 MINS LATER

24:17
So primary local PV use cases, for example, AI-enabled safety documentation production, work instructions and SOP, AI-assisted QA of documentations,
24:28
AI-assisted local literature monitoring, and that's just a couple.

We value your privacy

We use cookies to understand how you use our platform and to improve your experience. Click “Accept All” to consent, or “Decline non-essential” to opt out of non-essential cookies. Read our Privacy Policy.